Anita Moein

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Metastatic Renal Cell Carcinoma

Top Venues

Journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Anita Moein, Jin Y Jin, Matthew R Wright, Harvey Wong
Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure-Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor). Journal of clinical pharmacology (2024)
Anita Moein, Jin Y Jin, Matthew R Wright, Harvey Wong
Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure-Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor). Journal of clinical pharmacology 64 (9) (2024)
Anita Moein, Jin Y Jin, Matthew R Wright, Harvey Wong
Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure-Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor). Journal of clinical pharmacology 64 (9) (2024)